Drug Shortage Report for MED-DORZOLAMIDE-TIMOLOL
Report ID | 100744 |
Drug Identification Number | 02437686 |
Brand name | MED-DORZOLAMIDE-TIMOLOL |
Common or Proper name | Med- Dorzolamide Timolol |
Company Name | GENERIC MEDICAL PARTNERS INC |
Market Status | MARKETED |
Active Ingredient(s) | TIMOLOL DORZOLAMIDE |
Strength(s) | 5MG 20MG |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC |
Packaging size | 1 bottle |
ATC code | S01ED |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2019-12-10 |
Actual start date | 2019-12-10 |
Estimated end date | |
Actual end date | 2020-02-17 |
Shortage status | Resolved |
Updated date | 2021-04-23 |
Company comments | Med-Dorzolamide Timolol is not in shortage. The Shortage Report was not closed. This report is to state that the shortage ended a year ago. GMP has large amounts of stock. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1500 DON MILLS ROAD, SUITE 711 TORONTO, ONTARIO CANADA M3B 3K4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2021-04-23 | French | Compare |
v6 | 2021-04-23 | English | Compare |
v5 | 2019-12-11 | English | Compare |
v4 | 2019-12-10 | French | Compare |
v3 | 2019-12-10 | French | Compare |
v2 | 2019-12-10 | French | Compare |
v1 | 2019-12-10 | English | Compare |
Showing 1 to 7 of 7